Overview
Identification of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options, making comprehensive biomarker testing more important than ever to guide treatment. Molecular testing methods have correspondingly undergone significant expansion in both technological innovation and sensitivity.
This live, hybrid (both in-person and virtual) satellite symposium, held in conjunction with the Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo, will provide an in-depth review of this topic focusing on strategies to improve the application and interpretation of testing in NSCLC to identify actionable alterations and the latest data on the safety and efficacy of emerging targeted therapies.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Determine how multidisciplinary team members can mitigate barriers to testing and the interpretation of molecular marker results for patients with advanced NSCLC
- Outline the role of current and emerging biomarkers that facilitate personalized decision-making among patients with advanced NSCLC
- Determine guidelines and clinical trial data that facilitate the integration of targeted therapies and immunotherapies for the treatment of patients with advanced NSCLC
- Explain emerging molecular targets and precision-guided treatment strategies for the care of patients with advanced NSCLC
Program Chair
Lynette M. Scholl, MD
To view full profiles, click on the Program Chair tab above.
Lynette M. Scholl, MD
Associate Professor, Pathology
Harvard Medical School
Associate Pathologist, Pathology
Brigham and Women’s Hospital
Boston, MA
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.